Evidence map›Paper›PMID 40947690›Full record

ReviewMedicinal chemistry (Shariqah (United Arab Emirates))2026

Exploring Recent Advances in the Pharmacological Activities of Pyrazole Compounds: A Comprehensive Review.

Kunal Ganesh Raut, Anuruddha Rajaram Chabukswar, Priyanka Sanjay Waghmare, Swati Changdeo Jagdale, Onkar Gangaram Kachi, Hari Ragho Pawar

Abstract readReview
PubMed Publisher
In one paragraph

Review in Medicinal chemistry (Shariqah (United Arab Emirates)), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kunal Ganesh RautDepartment of Pharmaceutical Sciences, School of Health Sciences and Technology, Dr. Vishwanath Karad MIT World Peace University, Kothrud, Pune-411038, India.ORCID 0000-0002-3072-4953
Anuruddha Rajaram ChabukswarDepartment of Pharmaceutical Sciences, School of Health Sciences and Technology, Dr. Vishwanath Karad MIT World Peace University, Kothrud, Pune-411038, India.
Priyanka Sanjay WaghmareDepartment of Pharmaceutical Sciences, School of Health Sciences and Technology, Dr. Vishwanath Karad MIT World Peace University, Kothrud, Pune-411038, India.
Swati Changdeo JagdaleDepartment of Pharmaceutical Sciences, School of Health Sciences and Technology, Dr. Vishwanath Karad MIT World Peace University, Kothrud, Pune-411038, India.
Onkar Gangaram KachiDepartment of Chemistry, MES Abasaheb Garware College, Karve Road, Pune-411004, India.ORCID 0009-0005-6385-2969
Hari Ragho PawarDepartment of Chemistry, MES Abasaheb Garware College, Karve Road, Pune-411004, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pyrazole-based compounds have gained considerable attention in recent years due to their diverse and potent pharmacological properties. This review provides an up-to-date examination of the therapeutic potential of various substituted pyrazole derivatives, highlighting their roles in combating diseases such as cancer, tuberculosis, fungal and viral infections, inflammation, and others. Unlike previous reviews, this article emphasises newly reported analogues with significant bioactivity and structure-activity relationships (SAR), which may pave the way for future drug development. The novelty of this work lies in its integrated perspective that bridges medicinal chemistry innovations with therapeutic relevance, providing researchers with a valuable resource for designing next-generation drug candidates based on the pyrazole scaffold.

Indexed as

PyrazolesAnimalsAntifungal AgentsAnti-Inflammatory AgentsAntineoplastic AgentsAntitubercular AgentsHumansMolecular StructureNeoplasmsStructure-Activity RelationshipAntifungal AgentsAnti-Inflammatory AgentsAntineoplastic AgentsAntitubercular AgentsPyrazolesAnti-canceranti-fungalanti-tubercularheterocyclepharmacological activitypyrazole.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.